EpiPen Giant Smacked As Illinois Squeezes Out $8.25 Million
Illinois says it reached an $8.25M settlement with EpiPen maker Mylan, with most funds earmarked for Medicaid and state employee health plans and a bigger copay coupon for the generic. The announcement follows similar state deals this spring.












